title: [Investigation on the adequate administration interval with OK-432, using the cytotoxicity test].
authors.affiliation: Dept. of Head and Neck Surgery, Kanagawa Cancer Center.
authors.forename: M
authors.initials: M
authors.lastname: Tsukuda
authors.forename: S
authors.initials: S
authors.lastname: Furukawa
authors.forename: T
authors.initials: T
authors.lastname: Yoshida
authors.forename: S
authors.initials: S
authors.lastname: Yanoma
authors.forename: A
authors.initials: A
authors.lastname: Watanabe
authors.forename: K
authors.initials: K
authors.lastname: Takahashi
authors.forename: T
authors.initials: T
authors.lastname: Ono
authors.forename: S
authors.initials: S
authors.lastname: Sawaki
mesh_terms: D001688:Biological Products / Q000008:administration & dosage*; D003601:Cytotoxicity Tests, Immunologic; D004334:Drug Administration Schedule; D006801:Humans; D008297:Male; D008875:Middle Aged; D010610:Pharyngeal Neoplasms / Q000628:therapy*; D010844:Picibanil / Q000008:administration & dosage* / Q000627:therapeutic use
chemical_list: D001688:Biological Products; D010844:Picibanil